Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» GSK
GSK
GSK wins $235 million from Teva in Coreg patent trial
Reuters
Fri, 06/23/17 - 09:43 am
GSK
Teva Pharmaceutical
Coreg
patents
chronic heart failure
GSK’s Bexsero, Shingrix to pass $1B sales mark by 2022: report
Fierce Pharma
Wed, 06/21/17 - 11:01 am
GSK
Bexsero
Shingrix
vaccines
shingles
meningitis B
GSK's new pharma head to join in September after AstraZeneca tussle
Yahoo/Reuters
Mon, 06/19/17 - 11:34 pm
GSK
AstraZeneca
Luke Miels
GSK uses priority voucher to file HIV combo
BioPharma Dive
Sat, 06/3/17 - 09:20 am
GSK
priority review
HIV
ViiV
ViiV, GSK gamble a surprise $130M chip in a high-stakes HIV playoff with Gilead
Endpoints
Thu, 06/1/17 - 11:56 pm
GSK
ViiV
HIV
Pfizer’s Trumenba to challenge GlaxoSmithKline's Bexsero with EU nod
Fierce Pharma
Wed, 05/31/17 - 09:23 am
Pfizer
Trumenba
GSK
Bexsero
Europe
vaccines
meningococcal B
7 Things You Didn't Know About Gilead Sciences, Inc.
Motley Fool
Mon, 05/29/17 - 11:56 am
Gilead Sciences
GSK
cash flow
IPOs
Warren Buffett
GlaxoSmithKline's New CEO Is Off to a Good Start
Motley Fool
Mon, 05/29/17 - 11:54 am
GSK
Pharma CEOs
Emma Walmsley
Gilead needs to best Glaxo with bictegravir
EP Vantage
Thu, 05/18/17 - 12:14 am
Gilead Sciences
GSK
bictegravir
Dolutegravir
HIV
AstraZeneca throws a monkey wrench in new GSK CEO’s first hiring decision, suing Luke Miels
Endpoints
Tue, 05/16/17 - 11:31 am
GSK
Pharma CEOs
Emma Walmsley
AstraZeneca
Luke Miels
GlaxoSmithKline aims for the whole consumer-health shebang with $10.3B Novartis JV buyout
Fierce Pharma
Mon, 05/15/17 - 09:20 am
consumer health
M&A
GSK
Novartis
Glaxit: Flagging a looming threat from Gilead and a weak pipeline, Neil Woodford is giving up on GSK and pulling out
Endpoints
Fri, 05/12/17 - 09:44 am
Gilead Sciences
GSK
ViiV
Glaxo scores again as FDA strikes down would-be Advair copycats Hikma, Vectura
Fierce Pharma
Thu, 05/11/17 - 11:49 am
GSK
FDA
Advair
Hikma
Vectura
GlaxoSmithKline looks for Breo boost with landmark real-world asthma study
Fierce Pharma
Tue, 05/9/17 - 11:04 pm
GSK
Breo Ellipta
asthma
clinical trials
Here's What Wiped $3 Billion Off GlaxoSmithKline's Market Cap in April
Motley Fool
Thu, 05/4/17 - 09:47 am
GSK
Advair
Look out, Glaxo: Advair is Express Scripts' next big cost-savings target
Fierce Pharma
Wed, 05/3/17 - 11:00 am
GSK
Advair
Express Scripts
drug pricing
asthma
COPD
How Did GlaxoSmithKline’s Pharmaceuticals Segment Do in 1Q17?
Market Realist
Mon, 05/1/17 - 11:40 am
GSK
earnings
How Far Into the Drug Pipeline Should the FTC Reach?
TheStreet.com
Mon, 05/1/17 - 10:59 am
FTC
GSK
Novartis
BRAF inhibitor
MEK inhibitor
melanoma
Array Biopharma
M&A
New GlaxoSmithKline CEO wants fewer, bigger new drug launches
Yahoo/Reuters
Wed, 04/26/17 - 11:56 am
GSK
Pharma CEOs
Emma Walmsley
drug launches
GlaxoSmithKline’s 1Q17 Earnings: Analysts’ Estimates
Market Realist
Tue, 04/25/17 - 11:11 am
GSK
earnings
Pages
« first
‹ previous
…
47
48
49
50
51
52
53
54
55
…
next ›
last »